Navigation Links
Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
Date:11/6/2008

Advances in biotechnology and life science research coupled with broader range of application areas are expected to drive growth in the cell/tissue culture market. Growth is likely to be fueled by heightened interest in biopharmaceutical therapeutics, human and veterinary vaccine applications, and growing success of industrial biopharmaceuticals.

San Jose, CA (PRWEB) November 6, 2008 -- Cell culture is of vital importance in the life sciences industry for both research and industrial use. On the research front, cell cultures find extensive application in toxicology studies for initial-stage screening of compounds in drug discovery. The market is also expected to receive a shot in the arm as cell and tissue therapies emerge as one of the unique approaches to treating diseases. Further, funding for research on stem cells is expected to drive demand for cultures specific to stem cells.

Cell/tissue culture involves a diverse assortment of media, sera and reagents. Products essential for sustenance of cells grown in a defined mixture are termed as cell culture media. Cell culture media are pH-balanced blends of amino acids, salts, vitamins, and sugars, which supply essential nutrients required for cell growth in an artificial environment. Cell culture media includes a wide range of products, such as nutrient media solutions, powdered nutrient media, antibiotics, balanced salt solutions, buffers and stock reagent concentrates. Major application areas of cell/tissue culture include biotechnology, microbiology, medicine, pharmaceuticals, agriculture, cosmetics and food additives.

Global market for Cell/Tissue Culture Supplies is projected to reach US$4.96 billion by 2012, as stated in a recent report published by Global Industry Analysts, Inc. The US represents the largest market for cell/tissue culture supplies in the world with sales estimated at over US$1.27 billion for 2008. Reagents represents the largest as well as fastest growing product segment in the world with sales estimated at US$1.35 billion for 2008. The market is forecast to reflect a CAGR of 12.8% over the period 2008-2012. Global market for Sera is projected to reach US$1.11 billion by 2012.

Major players profiled in the report include Affymetrix Inc., AMRESCO Inc, Analytical Biological Services, BD Biosciences, Cell Culture Technologies, Cell Essentials Inc., Invitrogen Corporation, Irvine Scientific, Lonza Biologics Plc, Mediatech Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, USB Corp, Vitrolife AB, and Wisent Inc.

The report, titled "Cell/Tissue Culture Supplies: A Global Strategic Business Report" published by Global Industry Analysts, Inc. covers major market dynamics, trends, and competition pertaining to the market. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Product segments analyzed in the study include Media, Sera, and Reagents. Analysis for the period 2000 through 2015 is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.

For more details of this research report, please visit http://www.strategyr.com/Cell_Tissue_Culture_Supplies_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/cell_tissue_culture/supplies_reagents/prweb1568924.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
3. A Communitys Fight to Preserve its Historical and Rural Culture in Virginia: Biotechnology CEO Gets Involved
4. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
5. Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
8. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
9. Improved culture system for hepatitis C virus infection
10. LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
11. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... operational results for the three months ended December 31, 2016. ... -based life sciences and diagnostics company that develops and commercializes ... ... to build on the commercial milestones achieved in fiscal 2016," ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... 2017  Lexus, a returning partner of the Amgen Tour ... exclusive automobile partner of the men,s and women,s events for the ... 2017 Amgen Tour of California will mark ... the best professional cycling teams in the world racing from Northern ... Amgen Breakaway from Heart Disease TM Women,s Race ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):